BPB
AGN

Badgley, Phelps & Bell’s Allergan Inc AGN Stock Holding History

Badgley, Phelps & Bell’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-44,961
Closed -$9.56M – 179
2014
Q4 		$9.56M Sell
44,961
-804
-2% -$160K 0.94% 43
2014
Q3 		$8.15M Sell
45,765
-391
-0.8% -$64.9K 0.81% 54
2014
Q2 		$7.81M Sell
46,156
-15,499
-25% -$2.41M 0.78% 56
2014
Q1 		$7.65M Sell
61,655
-1,380
-2% -$168K 0.79% 56
2013
Q4 		$7M Sell
63,035
-737
-1% -$70.4K 0.74% 64
2013
Q3 		$5.77M Sell
63,772
-598
-0.9% -$53.7K 0.65% 69
2013
Q2 		$5.42M Buy
+64,370
New +$6.68M 0.64% 73

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Badgley, Phelps & Bell's AGN Position: Q1 2015 in Review

Badgley, Phelps & Bell sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 44,961 shares — an estimated $9.56M sold.

Badgley, Phelps & Bell first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $9.56M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Badgley, Phelps & Bell reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Badgley, Phelps & Bell sold 44,961 Allergan Inc shares in Q1 2015, an estimated $9.56M.
  • Badgley, Phelps & Bell first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Badgley, Phelps & Bell's Allergan Inc position peaked at $9.56M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Badgley, Phelps & Bell's 13F filing for Q1 2015, filed 6 May 2015.